Sat, Dec 20, 2014, 6:39 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Keryx Biopharmaceuticals Inc. Message Board

mgm2020 584 posts  |  Last Activity: 8 hours ago Member since: Mar 3, 2010
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Just wait until IDRA pops up on more investor's and institution's radars. This is the kind of stock that, despite the ups, downs, sideways movement, and market gyrations you are EXTREMELY GLAD that you bought and own in the long run. And the real run here is just beginning.

    Sentiment: Strong Buy

  • The IBB has moved from under 200 a few months ago to over 300 now. Developmental and early approval biotech IS the darling of the market once again. While you can slog along with a mega-cap or a blue chip that pays a dividend of a few percent, you can reap ENORMOUS gains with a stock at the stage that IDRA is. Each announced breakthrough is a possible 20, 30. 50. or 100% move up in the stock because it could be worth BILLIONS in either eventual products or BUYOUT like CBST this morning-----or partnerships, which WILL be coming with IDRA. Another presentation today. NASDAQ turned on a dime and I wouldn't be surprised to see IDRA do the same thing.

    Sentiment: Strong Buy

  • pull the trigger to sell, that's exactly where the stock will reverse and move higher. It's uncanny how that happens. But with IDRA, and at this point, there are PLENTY of buyers wanting to get in as the stock moves up, and plenty of upside here.

    Sentiment: Strong Buy

  • mgm2020 mgm2020 Dec 8, 2014 9:18 AM Flag

    Sorry---2015. My lysdexia took over.

    Sentiment: Strong Buy

  • as the stock works it's way back up to the highs from earlier this year-------and beyond. The 10 DMA chart shows an RSI right at 50 meaning the stock is not overbought, and the 3 an 6 month charts have moved back within the Bollinger Bands. Of course everyone saw the headlines on Cubist----CBST, being bought by Merck for $9.5 BILLION-----$102/share. Shows how desperate big pharma is now for new products, science, research, and products that are already in the development stage. Just keep looking at ISIS to see where IDRA----and the stock price----are headed. While you can be a "player" and try to trade the stock on every little move with a few hits and a few misses, I think with IDRA the better play is to "let it ride" and ADD on any brief drops now, as every new bit of positive news---and there will be a lot more coming, especially with Milano as the new CEO----will move the stock much higher quickly. To quote Steve Martin and Dan Ackroyd---2105 will be a WILD AND CRAZY year for IDRA!

    Sentiment: Strong Buy

  • mgm2020 mgm2020 Dec 7, 2014 6:44 PM Flag

    Is that one of those "Twilight Zone" phones that can show you the future? I hope so.

    Sentiment: Strong Buy

  • mgm2020 mgm2020 Dec 7, 2014 6:20 PM Flag

    News and expectation change everything. We had NO news for such a long time that the only direction the stock COULD move was down or tread water. Now we not only have good to great news coming from the company, seemingly on a regular basis in the last few weeks, but also a very high powered and success-driven CEO to lead the company higher. A drop would not be Unexpected, but a prolonged drop or more than a slight dip would be, as there has been so much buying lately , and I doubt those investors will be sellers. To the contrary, they will probably be looking to add with any drop.

    Sentiment: Strong Buy

  • Reply to

    Value of First Wind for SUNE

    by baxterjames120 Dec 6, 2014 11:11 AM
    mgm2020 mgm2020 Dec 6, 2014 12:16 PM Flag

    It shouldn't take long for the market to truly realize that there is NO correlation between low oil prices and the ever-increasing demand and need for solar/wind energy. It also won't take long for the stock to reach the $30 level and then $30 will be the new $20.

    Sentiment: Strong Buy

  • mgm2020 mgm2020 Dec 5, 2014 5:56 PM Flag

    There is a presentation at ISH on Sunday from 6-8PM Pacific time. Hopefully get a little pop on the open Monday. There is also another presentation on Monday.

    Sentiment: Strong Buy

  • more news from ASH and continuing into next week when we should continue moving higher. For everyone calling for a pullback----you got it yesterday when the stock dropped all the way to $3.85. That was it. No panic selling thinking the stock was going to drop like a rock. To the contrary, there was very strong buying following the morning dip. Same thing late this afternoon when the stock dropped below $4 to as low as $3.95 with people taking SOME profits but it was bought back up to close at $4.04. This is still too good an opportunity to pass up with ANY drop, and there are going be plenty of investors wishing they had bought yesterday or today when the stock crosses above $5 in the next few days to weeks. What an exciting last 2 weeks-----and the real excitement is just beginning!

    Sentiment: Strong Buy

  • Just kidding. Any long would have to have a couple of major screws loose if they felt that way after the week we've had. But I would be very surprised if the run didn't continue on Monday following ASH. Have a great weekend everyone.

    Sentiment: Strong Buy

  • mgm2020 mgm2020 Dec 5, 2014 3:22 PM Flag

    Got it. Misleading title.

    Sentiment: Strong Buy

  • Reply to

    What is that smell?

    by eldiviner Dec 5, 2014 2:09 PM
    mgm2020 mgm2020 Dec 5, 2014 2:47 PM Flag

    Just IDRA throwing a few more shorts in the fire!

    Sentiment: Strong Buy

  • mgm2020 mgm2020 Dec 5, 2014 2:46 PM Flag

    You are an imbecile----that's all. When I was over at KERX last year for the longest time there was a TROLL(poster) that went by Kolemup. He was always "shorting" the stock, except he would always announce that after the stock would pull back a little, until he started posting and kept posting as much negative garbage as he could, and everyone figured out that the more he posted, the more desperate the shorts were becoming. He would post stuff like the stock will be a penny stock in a few weeks, and of course that every drug trial would be a failure, the stock was going to tank, and on and on. Well the stock went from $6 to over $18 in less than a year, all of the drug trials were enormous successes and now they are sitting on an approved drug that will become available in a few weeks. You are nothing but a clueless cockroach who either is sitting on a short position that you never should have opened, or are getting paid for your meaningless posts. Either way-----you are a MORON!

    Sentiment: Strong Buy

  • mgm2020 mgm2020 Dec 5, 2014 1:49 PM Flag

    Here are the titles of the presentations. One of the presentations on lymphoma specifically excludes preclinical models:
    Idera Pharmaceuticals Announces Upcoming Presentations of Data From Oncology Programs at Key Scientific Meetings
    9:45a ET November 6, 2014 (GlobeNewswire) Print
    Idera Pharmaceuticals, Inc. (Nasdaq:IDRA), a clinical-stage biopharmaceutical company developing nucleic acid therapeutics for rare diseases, today announced the following data abstracts from its oncology programs were accepted for presentation at upcoming scientific meetings.

    56 Annual Meeting of the American Society of Hematology

    December 6-9, 2014; San Francisco, Calif.

    IMO-8400, an Antagonist of Toll-like Receptors 7, 8, and 9, in Development for Genetically Defined B-Cell Lymphomas: Safety and Activity in Phase 1 and Phase 2 Clinical Trials
    Session name: 624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models: Poster II
    Poster presentation time: Sunday, December 7, 2014, 6:00 - 8:00 p.m. PST
    Abstract: #3101
    Novel Approach to the Potential Treatment of Patients with B-Cell Lymphomas Harboring the MYD88 L265P Mutation: Combination Treatment with TLR Antagonist and Rituximab
    Session name: 625. Lymphoma: Pre-Clinical - Chemotherapy and Biologic Agents I
    Oral presentation time: Monday, December 8, 2014, 3:30 p.m. PST

    Sentiment: Strong Buy

  • Reply to

    I smell an offering.

    by hoodwinkr Dec 5, 2014 12:38 PM
    mgm2020 mgm2020 Dec 5, 2014 1:17 PM Flag

    It's not a mute point---it's a moot point! They still have to file for the specific offering and alert the SEC and shareholders. But----they have plenty of cash and the stock price will be much higher if and when they have a secondary.

    Sentiment: Strong Buy

  • Could have deja-vu all over again next week with another positive response to the presentations. And they are presenting another combination therapy lecture with TLR antagonists and rituximab with B-cell lymphomas AND P1 and P2 RESULTS -----NOT preclinical---of 8400 with genetically defined b-cell lymphoma. Now---do you think they would be presenting this data at ASH IF it wasn't clearly positive???

    Sentiment: Strong Buy

  • And with more good news from the presentations this weekend coming the stock could open and run much higher next week. I see the stock running back up to the previous high with minimal pullbacks along the way due to institutional support and buying once the stock reaches $5, along with the tremendous growth potential that both the science and the new CEO bring.

    Sentiment: Strong Buy

  • Reply to

    IDRA pps now up $1.00 since just last Friday

    by jacknjill777 Dec 5, 2014 10:15 AM
    mgm2020 mgm2020 Dec 5, 2014 10:57 AM Flag

    And the stock price is still almost $3, or 40% from the March high following some of the best and most encouraging news and developments in the company's history. While the rise from the bottom has been impressive---and long overdue, I still like the upside of this equation for a while-----at least until the stock passes the previous high, and depending on the upcoming presentations and early 2015 developments, could happen very quickly, decisively, and impressively.

    Sentiment: Strong Buy

  • really needs to open their eyes, and their mind, to the BIG PICTURE that is in the process of being painted by IDRA. All of the data that is being revealed and publicized at the very high visibility conferences this week and next along with the hiring of Mr. Milano, the new CEO who is known for value creation and stock appreciation(and looking for a "quality" offer when it comes to a buyout) shows that the stock is still considerably undervalued, and headed MUCH higher, and as ridiculous as it may sound to all of the "traders" and short-term holders, the latest move up from $2.00 needs to be viewed as a revaluation of the company and the stock based on all of the recent developments---which I expect to continue for a while, and not a trading opportunity thinking there will be a pullback---which I do NOT expect to happen-------yet. It will happen at some point as it does with every stock that moves up. but I do not think the revaluation higher is done and the stock could be--and SHOULD BE considerably higher before it finally takes a break. As the company has stated and Jim Baker of IDRA IR told me a few weeks ago-----2015 is going to be a very exciting year for IDRA---------and for US!

    Sentiment: Strong Buy

KERX
14.79+0.125(+0.85%)Dec 19 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.